Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2014 / Nov / The Road to Hell Is Paved with Good Intentions
Business and Entrepreneurship

The Road to Hell Is Paved with Good Intentions

Maurice Saatchi wants new legislation to free British doctors from fear of litigation in the pursuit of innovation. Others view it as a charlatan’s charter

By Mark Hillen 11/13/2014 1 min read

Share

There is a fantastic medical debate in the UK right now. In one corner, Maurice Saatchi, a man with no medical training but considerable clout in politics and media. In the other corner… most of the UK medical establishment. Saatchi’s Medical Innovation Bill (1) divides them. The bill has a great narrative – you’d expect nothing less from the guru of advertising. Doctors learn to “do no harm” – fine, until you’re dealing with dying patients. Here, “fear of the law” stops doctors from trying “innovative” therapies to save those patients – or advance medical knowledge. Saatchi’s opinion (2) is that “All 165,000 cancer deaths in this country every year are wasted deaths because science advances not one centimetre as a result,” adding, “Nothing new is tried […] Scientific progress is being halted by the law and fear of negligence bills.” Should something be done? The UK’s Health Secretary, Jeremy Hunt, thinks so and supports the bill.

Many doctors don’t. The Bolam test (3) is currently applied, and states that a doctor is only negligent and compensation justified “if no responsible body of medical opinion would support their treatment or if the treatment had no logical or rational justification.” Has the status quo stifled innovation? Unlikely. The NHS Litigation Authority states that such compensation claims are “vanishingly rare – 0.01 percent of such payments” (4). Might the bill help by codifying doctors’ stance and avoiding the need to interpret case law? If you innovate by “departing from the existing range of accepted treatments for a condition”, you must consult “with appropriately qualified colleagues” and consider “all matters that appear to the doctor to be reasonably necessary to be considered in order to reach a clinical judgment” (1). Already holes are being picked, such as “What counts as an appropriately qualified colleague?” (5). Perhaps future cases heard in court will clarify this...

Bills can be revised and loopholes closed. But I wonder how far science advances through anecdotal, ad hoc intervention? There’s no compulsion to publish or framework to pool those anecdotes to generate meaningful data. If you’re going to perform an intervention that risks depriving someone of peace or comfort in the last days of their life, then the information gathered better count for something. I see no guarantees that it will.

References

  1. House of Lords and M.N. Saatchi, “Medical Innovation Bill (HL)”, Stationery Office (2014). bit.ly/medinnovbill M. Saatchi, “Lord Saatchi Bill: We must liberate doctors to innovate”, January 28th (2014). bit.ly/mstelegraph Bolam v Friern Hospital Management ommittee (1957). bit.ly/bolamtest A. Prentice, “From The President: Medical Innovation Bill”, Bull. Royal Coll. Pathol., 167, 148–150 (2014). bit.ly/archieprentice  I. Brassington, “Saatchi Bill – Update” BMJ Blogs, October 28th (2014). bmj.co/107fs1l

About the Author(s)

Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

More Articles by Mark Hillen

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: